Fertility clinic

HRC Fertility Unveils First-Ever IVF Treatment Giveaway in Celebration of Its 35th Anniversary

Retrieved on: 
Wednesday, November 29, 2023
Women, Parenting, Children, Baby, Maternity, LGBTQ+, Family, Health, Consumer, General Health, HRC, Physician, Infertility, IVF, Fertility clinic, Pharmaceutical industry, Auction

HRC Fertility Center (HRC), one of Southern California’s most trusted fertility clinics, announced the launch of its first-ever IVF Treatment Giveaway.

Key Points: 
  • HRC Fertility Center (HRC), one of Southern California’s most trusted fertility clinics, announced the launch of its first-ever IVF Treatment Giveaway.
  • The inspiration behind this giveaway stems from HRC’s mission to make high-quality fertility treatment accessible and attainable for all deserving individuals and families.
  • Since announcing its more affordable anniversary specials in late July, HRC has sold nearly 1,000 egg freezing packages.
  • The IVF Treatment Giveaway offers three lucky individuals/families the chance to win the following prizes:
    First prize: $20,000 worth of services at an HRC location of your choice, including IVF treatment.

TMRW Life Sciences Expands Globally Entering UK Fertility Market

Retrieved on: 
Thursday, December 14, 2023
Fertility, Safety, Food, CRS, Patient, IVF, FDA, NHS foundation trust, CE, RFID, Fertility clinic, Software, Partnership, TMRW, Growth, Failure, Robotics, Certification, Medical device

NEW YORK, Dec. 14, 2023 /PRNewswire/ -- TMRW Life Sciences (TMRW), a fertility technology company automating the IVF lab, today announced its global expansion with the adoption of its technology in the United Kingdom (UK). The Hewitt Fertility Centre in Liverpool, England, will become the first clinic outside of the United States to adopt TMRW Life Sciences' CryoRobot Select (CRS), an automated platform for the safe management and storage of frozen eggs and embryos.

Key Points: 
  • NEW YORK, Dec. 14, 2023 /PRNewswire/ -- TMRW Life Sciences (TMRW), a fertility technology company automating the IVF lab, today announced its global expansion with the adoption of its technology in the United Kingdom (UK).
  • The Hewitt Fertility Centre in Liverpool, England, will become the first clinic outside of the United States to adopt TMRW Life Sciences' CryoRobot Select (CRS), an automated platform for the safe management and storage of frozen eggs and embryos.
  • But both efforts are overwhelming the legacy, manual storage systems and laborious hand-labelled identification methods that fertility clinics have relied upon for decades.
  • TMRW received a CE Mark for the CryoRobot Select in September, enabling commercialization across the UK and Europe.

TMRW Life Sciences Expands Globally Entering UK Fertility Market

Retrieved on: 
Thursday, December 14, 2023
Fertility, Safety, Food, CRS, Patient, IVF, FDA, NHS foundation trust, CE, RFID, Fertility clinic, Software, Partnership, TMRW, Growth, Failure, Robotics, Certification, Medical device

NEW YORK, Dec. 14, 2023 /PRNewswire/ -- TMRW Life Sciences (TMRW), a fertility technology company automating the IVF lab, today announced its global expansion with the adoption of its technology in the United Kingdom (UK). The Hewitt Fertility Centre in Liverpool, England, will become the first clinic outside of the United States to adopt TMRW Life Sciences' CryoRobot Select (CRS), an automated platform for the safe management and storage of frozen eggs and embryos.

Key Points: 
  • NEW YORK, Dec. 14, 2023 /PRNewswire/ -- TMRW Life Sciences (TMRW), a fertility technology company automating the IVF lab, today announced its global expansion with the adoption of its technology in the United Kingdom (UK).
  • The Hewitt Fertility Centre in Liverpool, England, will become the first clinic outside of the United States to adopt TMRW Life Sciences' CryoRobot Select (CRS), an automated platform for the safe management and storage of frozen eggs and embryos.
  • But both efforts are overwhelming the legacy, manual storage systems and laborious hand-labelled identification methods that fertility clinics have relied upon for decades.
  • TMRW received a CE Mark for the CryoRobot Select in September, enabling commercialization across the UK and Europe.

Kindbody Reports High Growth; Positioning Itself as Fertility and Family-Building Leader Serving Employers and Consumers

Retrieved on: 
Tuesday, December 5, 2023
EBITDA, Fertility, Investment, Patient, Growth, CFOS, Fertility clinic, Employment, Education, Deloitte Technology Fast 500, Transport, Health insurance, Nursing

NEW YORK, Dec. 5, 2023 /PRNewswire/ -- Kindbody, the leading national fertility clinic network and global family-building benefits provider for employers, today announced that it is on track to generate revenue of approximately $180 million in fiscal year 2023. This represents 50% organic year-over-year growth, positioning Kindbody as a leader among its healthcare and fertility peers today and earning it a top ten percent ranking on the 2023 Deloitte Technology Fast 500™ list.

Key Points: 
  • Kindbody's model is unique in that it is the only family-building benefits provider for employers that owns and operates fertility clinics.
  • The Company guarantees savings of 25%-30% to employers by contracting directly with Kindbody to provide comprehensive virtual and in-person care for their employees.
  • As the direct provider of care, Kindbody is uniquely positioned to decrease cost, improve the patient experience, and deliver better health outcomes.
  • Employers who wish to learn more about how Kindbody delivers the best patient experience and outcomes while reducing healthcare costs can contact [email protected]

Next Fertility Selects Fairtility's CHLOE™ Transparent AI Decision Support Technology for Network Clinics Across Spain

Retrieved on: 
Wednesday, November 15, 2023
Electronic health record, Empowerment, Fertility, Entrepreneurship, Database, Patient, EMR, TLI, IVF, Laboratory, Patient satisfaction, Data collection, Communication, Uterus, Judgement, NEXT, TEL, Embryo, Fertility clinic, Mineral oil, Birth control, Nursing

TEL AVIV, Israel, Nov. 15, 2023 /PRNewswire/ -- Fairtility, the transparent AI innovator powering reproductive care for improved outcomes, today announced that Next Fertility, part of Next Clinics, an international group and one of Europe's largest assisted reproduction and healthcare providers, has chosen to implement CHLOE™ across its fertility clinics in Spain.

Key Points: 
  • Following a successful trial period, Next Fertility elected to expand its implementation of Fairtility's technology, from one clinic – Next Fertility Murcia, across all seven group clinics in Spain.
  • Next Fertility clinics in Murcia, Valencia, Sevilla, Madrid, Huelva, Burgos and Vitoria will all utilize CHLOE EQ to support embryo quality assessment in labs.
  • By interconnecting the various systems in labs across the NEXT Fertility network in Spain, CHLOE will automate and standardize data collection and analysis processes and streamline workflows for maximum efficiency across network clinics.
  • Next Fertility is part of Next Clinics and is one of Europe's largest reproductive care networks with clinics across eight countries with 22 IVF clinics and seven diagnostics laboratories operating across the network.

Kindbody Ranked No. 30 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

Retrieved on: 
Wednesday, November 8, 2023
Fertility, Female, Digital, Business Leaders for Michigan, Genetic testing, CNBC, Physician, Fertility clinic, Marital status, Male, Deloitte Technology Fast 500, Gender identity, IVF, Growth, Partnership, Telecommunications, Patient, Fertility preservation, Mental health, Nursing

NEW YORK, Nov. 8, 2023 /PRNewswire/ -- Kindbody, the leading national fertility clinic network and global family-building benefits provider for employers, today announced it was ranked No. 30 on the Deloitte Technology Fast 500™, which recognizes the fastest growing and most innovative technology companies in North America. Kindbody grew nearly 6,000% during the period of 2019 to 2022 due to the growing demand for fertility and family-building care from employers and patients nationwide.

Key Points: 
  • 30 on the Deloitte Technology Fast 500 ™, which recognizes the fastest growing and most innovative technology companies in North America.
  • "We are thrilled to receive this honor from Deloitte and be recognized alongside so many of the world's most innovative companies," said Scott Bruckner, Chief Financial Officer of Kindbody.
  • Placement on the Deloitte Technology Fast 500 is the latest in the string of growth, innovation, and workplace-related recognition Kindbody has garnered in 2023.
  • Employers who wish to learn more about how Kindbody delivers the best patient experience and outcomes while reducing healthcare costs can contact [email protected] .

Inception Fertility Appoints Lindsey Rabaut as Chief Marketing Officer

Retrieved on: 
Wednesday, November 8, 2023
Knowledge, University of Cincinnati – College-Conservatory of Music, Fertility, System, Health, Family, Fertility clinic, University, Procter & Gamble, Kelley School of Business, Bachelor of Fine Arts, Business administration, Marketing, Business, Brand management, Procter, Abbott Laboratories, Love, Indiana University, CMO, ILY, Management, Rabaut, Inception, Music

HOUSTON, Nov. 8, 2023 /PRNewswire/ -- Inception Fertility™ (Inception), the largest provider of comprehensive fertility services across North America, announces today the appointment of Lindsey Rabaut as its new Chief Marketing Officer (CMO). 

Key Points: 
  • HOUSTON, Nov. 8, 2023 /PRNewswire/ -- Inception Fertility ™ (Inception), the largest provider of comprehensive fertility services across North America, announces today the appointment of Lindsey Rabaut as its new Chief Marketing Officer (CMO).
  • An accomplished CMO, Rabaut has over 12 years of marketing and brand management experience within Fortune 100 and private equity-backed companies, specializing in consumer segmentation, portfolio mix, digital and shopper marketing, and full-funnel attribution.
  • As CMO at Inception, Rabaut will lead the organization's expansive marketing and communications efforts, including executing omnichannel and go-to-market initiatives, driving brand awareness, and leading public relations efforts.
  • "We are excited to welcome Lindsey into the Inception family and look forward to the contributions she will make to amplify our strong position within the industry."

Clinics within The Prelude Network ® Recognized by the Society for Assisted Reproductive Technology for Excellence in Fertility Care Services and Reporting

Retrieved on: 
Tuesday, November 7, 2023
Science, American Society for Reproductive Medicine, SART, Fertility, Inception, RBA, Fertility clinic, Health, Society, ART, Reproductive medicine, IVF, Quality assurance, Dream, REI, Assisted reproductive technology, Partner, ASRM, Woman, Safety, Patient, Human Biology Association, Reproductive endocrinology and infertility, Parent, Birth control, Nursing

HOUSTON, Nov. 7, 2023 /PRNewswire/ -- The Prelude Network®, the largest network of fertility clinics in North America, announces today that two of its clinics have been recognized by the Society for Assisted Reproductive Technology (SART), with Reproductive Biology Associates (RBA) in Atlanta, Georgia receiving a SART Platinum designation and IVFMD in Miami, Florida receiving a SART Gold designation.

Key Points: 
  • HOUSTON, Nov. 7, 2023 /PRNewswire/ -- The Prelude Network ®, the largest network of fertility clinics in North America, announces today that two of its clinics have been recognized by the Society for Assisted Reproductive Technology (SART), with Reproductive Biology Associates (RBA) in Atlanta, Georgia receiving a SART Platinum designation and IVFMD in Miami, Florida receiving a SART Gold designation.
  • This recognition is a joint selection by SART's Quality Assurance and Validation Committees to recognize clinics for their excellence in prospective reporting and for following guidance set forth by the American Society for Reproductive Medicine (ASRM) and SART.
  • "It is a testament of their dedication to patients and the field of reproductive medicine to uphold, practice, and deliver the highest standards in fertility care."
  • The clinic provides patient-centric, individualized care that offers patients the latest science and technologies in fertility medicine.

Asia Pacific Emerges as High-Growth Hub for Preimplantation Genetic Testing, Fueled by Economic Growth and Rising Fertility Clinics - ResearchAndMarkets.com

Retrieved on: 
Monday, October 30, 2023
Biotechnology, Consumer, Health, Genetics, Baby, Maternity, Aneuploidy, Mosaic, Child, Genetic testing, Fertility clinic, Region, PCR, Chromosome abnormality, SNP, Consumables, Miscarriage, IVF, Growth, NGS, Diagnosis, Risk, CGH, USD, HLA, Chromosome, Agriculture, Application

The global preimplantation genetic testing market is on an upward trajectory, poised to hit USD 1.2 billion by 2028, according to recent projections.

Key Points: 
  • The global preimplantation genetic testing market is on an upward trajectory, poised to hit USD 1.2 billion by 2028, according to recent projections.
  • However, the growth is not without its challenges, as unfavorable government regulations and healthcare reforms for IVF procedures are impeding progress in the preimplantation genetic testing sector.
  • Regionally, the Asia Pacific region is positioned for the highest growth rate in the preimplantation genetic testing market.
  • The rapid economic growth in emerging countries like China and India has led to increased disposable income levels, presenting significant potential for the Asia Pacific preimplantation genetic testing market.

Military Families Campaign Raises Awareness of Infertility in the Military Community, Expands Access to Quality Care to Veterans and Active-Duty Service Members

Retrieved on: 
Wednesday, November 1, 2023
American Society for Reproductive Medicine, National Veterans Memorial and Museum, Desert Uniforms, Patches, and Insignia of the US Armed Forces, Fertility, Inception, Military personnel, Fertility clinic, Parent, Veteran, Society, United States Department of Veterans Affairs, Practice, Learning, Reproductive medicine, IVF, Pregnancy, Aspire, REI, ASRM, Woman, Patient, IUI, Reproductive endocrinology and infertility, Infertility, VA, Health insurance, Birth control, Nursing, Prelude

HOUSTON, Nov. 1, 2023 /PRNewswire/ -- In celebration of National Veteran and Military Families Month  The Prelude Network® (Prelude) honors the members of the US Armed Forces by expanding accessibility to premium reproductive services to veterans and active-duty personnel through its Military Families Month campaign.

Key Points: 
  • HOUSTON, Nov. 1, 2023 /PRNewswire/ -- In celebration of National Veteran and Military Families Month The Prelude Network ® (Prelude) honors the members of the US Armed Forces by expanding accessibility to premium reproductive services to veterans and active-duty personnel through its Military Families Month campaign.
  • Historically, accessing fertility services has been limited for service members as they must meet stringent criteria set by the Department of Veterans Affairs (VA).
  • "Through our Military Families campaign, Inception is doing its part honor, serve, and support our military members by helping improve that accessibility."
  • For active and retired service members interested in learning more about Prelude's Military Families Month offer, please visit Prelude's Military Families Campaign page.